Insiders · BIIB

Robin Kramer

Chief Financial Officer at Biogen Inc. (BIIB)

Robin Kramer has filed 32 insider reports with the SEC since February 2021, as director at Armata Pharmaceuticals, Inc. (ARMP) and chief Financial Officer at Biogen Inc. (BIIB). The latest filing, on March 12, 2026, reports grant or award at Armata Pharmaceuticals, Inc. (ARMP).

Filings
32
Companies
2
Bought on market
None
Sold on market
None

Companies where Robin Kramer is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Armata Pharmaceuticals, Inc. logo
ARMP
Armata Pharmaceuticals, Inc.
Director$3.17Mar 12, 2026
Biogen Inc. logo
BIIB
Biogen Inc.
Chief Financial Officer11,472$251.41Feb 18, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robin Kramer with

Other insiders at the same companies

Questions about Robin Kramer

What is Robin Kramer's role at Biogen Inc.?
Robin Kramer reports to the SEC as chief Financial Officer at Biogen Inc. (BIIB), according to the latest filing on February 18, 2026. Robin Kramer has also filed as director at Armata Pharmaceuticals, Inc. (ARMP).
How many shares does Robin Kramer own?
After the latest filing that states it, Robin Kramer directly owned 11,472 shares of Biogen Inc. (BIIB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robin Kramer bought or sold stock recently?
No open-market purchases or sales by Robin Kramer are on file. The filings report grant or award, shares withheld for taxes or exercise price, exercise or conversion of a derivative and other acquisition or disposition.
How do I get alerts when Robin Kramer files?
Follow Robin Kramer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robin Kramer (SEC CIK 0001609222). Totals count each trade once, skipping amendments whose original is on file, from Feb 17, 2021 on. View on SEC EDGAR